Granulomatosis with Polyangiitis
📧 Sign up to get email alerts when something new happens for Granulomatosis with Polyangiitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach [Phase 3]
Phase 3 trial results for prednisone in remission in granulomatosis with polyangiitis have been completed with results posted.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases [Phase 4]
Phase 4 clinical trial assessing safety and immunogenicity of the live attenuated tetravalent Butantan-Dengue vaccine in autoimmune rheumati…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis [Phase 3]
This clinical trial update describes a Phase 3 study evaluating salvage therapy for granulomatosis with polyangiitis (ANCA-associated vascul…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Study of One Protein Implicated in Wegener Disease [NA]
A completed clinical trial in Paris evaluated one protein implicated in Granulomatosis with polyangiitis (Wegener's granulomatosis).
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach [Phase 3]
Phase 3 clinical trial evaluating prednisone for remission in granulomatosis with polyangiitis has completed, under a Centers of Excellence …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis [Phase 2]
A Phase 2 clinical trial evaluating obinutuzumab as induction therapy for remission in relapsing PR3-ANCA granulomatosis with polyangiitis i…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis. [Phase 4]
A Phase 4 clinical trial comparing clinico-biological monitoring to pre-emptive rituximab for ANCA reappearance in granulomatosis with polya…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA [Phase 2]
A Phase 2 clinical trial is evaluating rapcabtagene autoleucel for severe active granulomatosis with polyangiitis and microscopic polyangiit…
-
EMA trial_result · 2026-01-30EMA starts review of Tavneos, a medicine for rare autoimmune diseases GPA and MPA
The EMA has started a review of Tavneos (avacopan) after questions were raised about the integrity of data from the main pivotal study in gr…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW) [Phase 3]
The SAFE-LOW Phase 3 trial evaluating low-dose glucocorticoids for ANCA-associated vasculitis is currently recruiting, focusing on granuloma…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Vasculitis Pregnancy Registry
Clinical trial update for a pregnancy registry in vasculitis sponsored by the University of Pennsylvania, currently recruiting to evaluate p…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis [Phase 2]
A Phase 2 clinical trial evaluating low-dose naltrexone for improving physical health in patients with vasculitis has completed.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
A clinical trial update for the CUTIS study, which is recruiting to study transcriptomics in systemic vasculitis conditions.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: One-Time DNA Study for Vasculitis
A University of Pennsylvania-led trial is recruiting for a one-time DNA study of various vasculitides, including eosinophilic granulomatosis…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: VCRC Tissue Repository
The University of Pennsylvania–sponsored VCRC Tissue Repository trial is currently recruiting. It covers multiple forms of vasculitis.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator
A completed clinical trial comparing rituximab biosimilars to the originator in ANCA-associated vasculitis, including granulomatosis with po…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) [Phase 1]
Phase 1 clinical trial update for SC291 in severe B-cell–mediated autoimmune diseases; the study is active but not recruiting and includes s…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Efficacy Study of Two Treatments in the Remission of Vasculitis [Phase 3]
Phase 3 trial update evaluating two treatments for inducing remission in granulomatosis with polyangiitis and microscopic polyangiitis; the …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis [Phase 1, Phase 2]
Clinical trial update for the TEMPO study evaluating trimethoprim-sulfamethoxazole in granulomatosis with polyangiitis, a Phase 1/2 study cu…
-
EMA approval · 2025-10-06EMA Authorised: Rixathon (rituximab) — Sandoz GmbH
EMA authorised Rixathon (rituximab) by Sandoz as a biosimilar to Rituxan for several autoimmune and hematologic diseases, expanding access t…
-
EMA approval · 2025-09-29EMA Authorised: Truxima (rituximab) — Celltrion Healthcare Hungary Kft.
EMA authorised Truxima (rituximab) by Celltrion Healthcare Hungary Kft. as a biosimilar rituximab for several indications including Non-Hodg…
-
CLINICAL_TRIALS other · 2025-09-19Clinical Trial Update: TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis [Phase 2, Phase 3]
Clinical trial update indicates a Phase 2/3 study of avacopan (TAVNEOS) for otolaryngologic manifestations of granulomatosis with polyangiit…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis. [NA]
A clinical trial is evaluating whether extended prednisone maintenance can sustain remission in granulomatosis with polyangiitis (ANCA-assoc…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
A completed clinical trial investigates whether neutrophil levels can serve as prognostic indicators in granulomatosis with polyangiitis.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis [Phase 3]
Phase 3 trial comparing two rituximab regimens for maintaining or achieving remission in ANCA-associated vasculitis has completed.